Factor VIII Coagulation Products
Factor VIII products are used to manage acute bleeding or to prevent excessive bleeding as a treatment for patients with hemophilia A and/or von Willebrand disease.
Nufactor carries the following F.D.A.-approved Factor VIII products:
* denotes that Nufactor does not currently carry this product.
Product
Manufacturer
FDA-Approved Indication
Factor VIII
Product: ADVATE
Manufacturer: Shire
FDA-Approved Indication:
Hemophilia A
Product: AFSTYLA®
Manufacturer: CSL Behring
FDA-Approved Indication:
Hemophilia A
Product: Alphanate®
Manufacturer: Grifols
FDA-Approved Indication:
Hemophilia A, von Willebrand
(not indicated for patients with severe VWD (Type 3) undergoing major surgery.)
(not indicated for patients with severe VWD (Type 3) undergoing major surgery.)
Product: ELOCTATE®
Manufacturer: Bioverativ
FDA-Approved Indication:
Hemophilia A
Product: Helixate® FS
Manufacturer: CSL Behring
FDA-Approved Indication:
Hemophilia A
Product: Hemofil M
Manufacturer: Shire
FDA-Approved Indication:
Hemophilia A
Product: Humate-P®
Manufacturer: CSL Behring
FDA-Approved Indication:
Hemophilia A
Product: Koate®-DVI
Manufacturer: Kedrion
FDA-Approved Indication:
Hemophilia A
Product: Kogenate® FS
Manufacturer: Bayer
FDA-Approved Indication:
Hemophilia A
Product: KOVALTRY®
Manufacturer: Bayer
FDA-Approved Indication:
Hemophilia A
Product: Monoclate®-P
Manufacturer: CSL Behring
FDA-Approved Indication:
Hemophilia A
Product: Novoeight®
Manufacturer: Novo Nordisk
FDA-Approved Indication:
Hemophilia A
Product: NUWIQ®
Manufacturer: Octapharma USA
FDA-Approved Indication:
Hemophilia A
Product: Recombinate®
Manufacturer: Baxalta
FDA-Approved Indication:
Hemophilia A
Product: Wilate®
Manufacturer: Octapharma
FDA-Approved Indication:
von Willebrand
Product: XYNTHA®
Manufacturer: Pfizer
FDA-Approved Indication:
Hemophilia A
